Expression of Vascular Endothelial Growth Factor, Apoptosis Inhibitors (Survivin and p16) and CCL27 in Alopecia Areata Before and After Diphencyprone Treatment: An Immunohistochemical Study
May 2004
in “
British Journal of Dermatology
”
TLDR Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.
The study investigated the effects of topical immunotherapy on alopecia areata (AA) by examining the expression of vascular endothelial growth factor (VEGF), apoptosis inhibitors (survivin and p16), and CCL27 before and after treatment with diphencyprone (DPC). It found that the treatment played a significant role in promoting angiogenesis by upregulating VEGF in hair follicle keratinocytes and enhancing survivin to maintain endothelial cell viability. Additionally, the therapy altered the peribulbar CD4/CD8 ratio, bringing it closer to that of normal scalp skin. These findings contributed to understanding the pathogenesis of AA and the mechanisms by which DPC might act in this complex condition.